Allied CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
Calum Hughes resigned as Chief Executive Officer and a Director of Allied Corp., effective January 30, 2025.
OTC.Pink
Allied Corp has announced its decision to voluntarily cease trading on the OTCQB and terminate its SEC registration to redirect resources towards growth initiatives.
OTC.Pink
Allied Corp. has successfully shipped 30kg of medical cannabis to its Portuguese partner, marking the start of a UK supply contract expected to generate at least $360,000 in annual revenue.
OTC.Pink
Allied Corp.'s subsidiary, Allied Colombia S.A.S., has entered into a five-year forward purchase agreement to supply medical-grade cannabis to CanPoland for distribution in Poland.
OTC.Pink
Allied Corp. has successfully released its first GMP-certified medical cannabis product into the Swiss market, marking a significant milestone for the company.
OTC.Pink
Allied Corp. reports the departure of Chief Financial Officer, Ryan Maarschalk, effective August 19, 2024.
OTC.Pink
Allied Corp has successfully completed a 180kg shipment of medical cannabis to an EU-GMP manufacturer, marking a significant step in their international expansion.
OTC.Pink
Allied Corp. reports the resignation of a director and the relocation of its headquarters.